Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Sanofi India Q1 net...

    Sanofi India Q1 net profit dips 27% at Rs 60 cr

    Written by Ruby Khatun Khatun Published On 8 May 2017 12:17 PM  |  Updated On 8 May 2017 12:17 PM
    Sanofi India Q1 net profit dips 27% at Rs 60 cr

    New Delhi: Drug firm Sanofi India reported a 27.36 per cent dip in standalone net profit to Rs 60 crore for the first quarter ended March 31, 2017 on account of price reduction of drugs in the country and lower exports.


    The company had posted a net profit of Rs 82.6 crore for the corresponding period of previous fiscal, Sanofi India said in a BSE filing.


    Standalone total revenue from operations also declined to Rs 552.9 crore for the quarter under consideration as against Rs 556.5 crore in 2015-16.



    The company follows January-December financial year.

    "Lower export volumes and rupee appreciation versus euro had an adverse impact on sales and profitability for the quarter ended March 31, 2017," Sanofi India said.


    The profit for the quarter ended March 31, 2017 as compared to the same quarter of the previous fiscal has also been impacted due to price reduction following the fixation of the ceiling prices under Drug Prices Control Order (DPCO) 2013, it added.


    Shares of Sanofi India closed 1.23 per cent down at Rs 4,180.75 on BSE. PTI AKT SRK

    27.36 per cent dipDPCODrug Prices Control Orderfirst quarternet profitprice reduction of drugsrevenueRs 60 croreSanofi India Ltd
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok